When a baby's blood count falls dangerously low in the womb,
we give new blood — before birth.
Intrauterine fetal blood transfusion (IUT) is a life-saving procedure in which donor red blood cells are delivered directly into the baby's umbilical vein — correcting severe anaemia while the baby is still in the womb and the pregnancy can safely continue.
When a baby becomes severely anaemic before birth — most commonly because of Rh alloimmunisation (Rh disease) or parvovirus B19 infection — its heart works harder and harder to deliver oxygen to its organs. Without treatment, this leads to high-output cardiac failure, hydrops fetalis (dangerous fluid build-up throughout the body), and can be fatal. Transfusion reverses this process: the baby's haemoglobin is restored, cardiac function improves, and the pregnancy can continue to a safe gestational age for delivery.
At Mayflower Fetal Medicine Centre, intrauterine fetal blood transfusion is performed under continuous GE Voluson Signature Expert guidance by Dr. Kunda Shahane — the pioneer of this procedure in Vidarbha and the only specialist currently performing it in Central India.
Intrauterine transfusion does not happen in isolation — it is the treatment step at the end of a carefully monitored clinical pathway. Understanding the full journey helps families know what to expect at each stage.
The pathway begins when an Rh-negative mother is found to have anti-D (or other) antibodies in her blood during pregnancy — or when a maternal parvovirus B19 infection is confirmed. These are the triggers for close fetal monitoring.
Trigger for MonitoringDr. Kunda Shahane monitors the Middle Cerebral Artery (MCA) peak systolic velocity (PSV) every 1–2 weeks. An anaemic baby has a faster heartbeat, which drives blood more quickly through the MCA — a raised MCA PSV is the first sign that anaemia may be developing. As long as MCA PSV remains below 1.5 MoM (multiples of the median), the pregnancy is monitored closely without intervention.
Non-Invasive MonitoringWhen MCA PSV rises above 1.5 MoM — the internationally accepted threshold for likely moderate-to-severe anaemia — cordocentesis is performed. A small sample of fetal blood is collected to directly measure haemoglobin and haematocrit, confirming the diagnosis and calculating the precise volume of blood needed for transfusion.
Diagnostic ProcedureIf the haemoglobin confirms significant anaemia, Dr. Kunda Shahane proceeds immediately to transfusion through the same needle — without removal and reinsertion. Specially prepared donor red blood cells are infused slowly into the umbilical vein while the fetal heart rate is monitored continuously throughout. The target haemoglobin is restored to a safe level.
Life-Saving TreatmentImmediately after transfusion, the MCA PSV falls dramatically — reflecting the corrected haemoglobin. The baby is monitored closely in the clinic and MCA Doppler is rechecked. As the transfused red cells are gradually broken down over 2–4 weeks, the MCA PSV rises again — signalling when the next transfusion is needed.
Recovery and MonitoringSteps 3–5 repeat every 2–4 weeks — as many times as needed — until the baby reaches a gestational age (typically 34–37 weeks) where delivery is safer than continued transfusion. After the final transfusion, delivery is planned and coordinated with the obstetric team. Most babies born after a successful IUT series do well.
Until DeliveryFetal anaemia severe enough to require intrauterine transfusion has specific causes — all involving the destruction or failure of fetal red blood cell production. Dr. Kunda Shahane manages all of the following conditions at Mayflower Clinic.
The most common cause. An Rh-negative mother whose baby is Rh-positive produces antibodies (anti-D) that cross the placenta and destroy the baby's red blood cells. Severity worsens with each affected pregnancy. Prevented by timely Anti-D injections — but if sensitisation has already occurred, serial IUT is the treatment.
Most Common CauseParvovirus B19 (fifth disease) infects fetal red blood cell precursors, halting production for 4–8 weeks. In the second trimester, this can cause severe aplastic anaemia and hydrops. Transfusion "buys time" while the baby's own bone marrow recovers — usually requiring only 1–2 transfusions.
Often Resolves After 1–2 IUTAntibodies to other red cell antigens — anti-Kell (Kell system), anti-c (Rh system), anti-E, and others — can cause haemolytic disease of the fetus. Anti-Kell is particularly severe as it suppresses fetal red cell production in addition to destroying existing cells. Management mirrors anti-D disease.
Similar to Rh DiseaseIn some cases of non-immune hydrops (hydrops not caused by antibody-mediated haemolysis), fetal anaemia is discovered as the underlying cause — including in alpha-thalassaemia major (Bart's hydrops). Transfusion may stabilise some of these cases while the full diagnosis is pursued.
Selected CasesThe blood used for intrauterine fetal transfusion is not standard blood bank blood. It must meet very strict specifications to be safe for a fetus — and it is arranged by Dr. Kunda Shahane in advance of every procedure.
Each transfusion session begins with a complete clinical and ultrasound assessment. No two sessions are identical — fetal position, cord location, and haemoglobin level vary each time.
Current MCA peak systolic velocity is measured and compared to the expected normal range (MoM) for gestational age. This determines whether the threshold for transfusion has been reached.
Biophysical profile or CTG to assess fetal activity, tone, breathing movements, and amniotic fluid — overall fetal wellbeing before a technically demanding procedure.
Detailed scan to identify the cord insertion site, fetal lie, and placental position — determining the safest needle entry point for this specific session.
Confirming that the specially prepared donor blood (irradiated, CMV-negative, O-negative) has arrived and is within the acceptable freshness window before beginning. No transfusion proceeds without this confirmation.
Using the pre-transfusion haemoglobin (measured from the initial blood sample), the estimated fetal weight, and the haematocrit of the donor blood to calculate precisely how much blood needs to be transfused to reach the target haemoglobin level.
Review of maternal antibody titres, any interval clinical changes, and confirmation of Rh-negative status and Anti-D prophylaxis — ensuring the maternal health picture is stable before proceeding.
Each IUT session takes approximately 30–60 minutes from needle insertion to completion, though your total time at the clinic will be longer. You will be awake and comfortable throughout.
Dr. Kunda performs a full assessment — MCA Doppler, fetal wellbeing check, and cord position mapping on the GE Voluson Signature Expert. Donor blood identity and specifications are verified against the patient's details. The procedure does not begin until every check is complete.
The abdominal skin is cleaned with antiseptic solution. You are positioned comfortably on the procedure table. Local anaesthesia is generally not required — the needle is fine and the discomfort is similar to a blood test.
Under continuous real-time ultrasound guidance, a fine needle is directed into the umbilical vein — ideally at the cord insertion into the placenta, where the cord is most stable. The flash of bright fetal blood confirms correct placement in the vein.
A small blood sample (1–2 mL) is collected first — sent to the bedside analyser for immediate haemoglobin and haematocrit measurement. This confirms the severity of anaemia and is used to calculate the exact volume of donor blood needed.
The calculated volume of pre-warmed donor packed red cells is transfused slowly through the same needle into the umbilical vein. The fetal heart rate is monitored continuously by the ultrasound operator throughout, and the needle position is checked regularly. The transfusion takes 15–45 minutes depending on the volume required.
After transfusion, a second blood sample confirms the post-transfusion haemoglobin — verifying the target level has been achieved. The fetal heart rate and cord entry site are checked by ultrasound before the needle is removed.
You rest at the clinic for 30–60 minutes while fetal heart rate is monitored. Dr. Kunda confirms fetal wellbeing before discharge. The date and timing of the next MCA Doppler check — and the estimated date of the next transfusion — are discussed before you leave.
"There are moments in fetal medicine that stay with you for life. The moment a severely anaemic baby — whose heart was racing and whose body was filling with fluid — receives its first transfusion, and the heart rate settles, and the MCA Doppler normalises on the screen in front of you. The baby has been given a chance it would not otherwise have had. Bringing this procedure to Vidarbha — so that families from Nagpur, Amravati, and Wardha no longer need to make that desperate two-hour drive to Mumbai every fortnight — is work I am genuinely proud of. Every transfusion is a fight for a life. We do not take that lightly."
Related Services at Mayflower Clinic
If you have been diagnosed with Rh disease, parvovirus B19 infection, or elevated MCA Doppler, time matters. Dr. Kunda Shahane is the only specialist in Central India performing intrauterine fetal blood transfusion. Contact us immediately — we prioritise urgent referrals.
Mayflower Fetal Medicine Centre · Dhantoli, Nagpur 440012 · Monday–Saturday 10:00 AM – 6:00 PM · Emergency WhatsApp 24×7
Mayflower Fetal Medicine & High-Risk Pregnancy Centre, Dhantoli, Nagpur, provides fetal ultrasound, prenatal diagnosis, fetal echocardiography, Doppler studies, genetic counseling and high-risk pregnancy care under Dr. Kunda Shahane.

Fetal Echocardiography: Detecting Heart Defects before Birth…

High-Risk Pregnancy: How Fetal Medicine Supports Moms…
Surdham Complex, Behind Silver Palace Building, 2nd Lane from Panchsheel Sq., Opp. Yashwant Stadium, Dhantoli Nagpur - 440012
07126692706
whatsapp 8087471244
